Literature DB >> 16198957

Papillary endobronchial squamous cell carcinoma.

Lynn Cooper1, Jennifer K Hagenschneider, Sadra Banky, Melissa L Rosado-de-Christenson, Saul Suster.   

Abstract

A case of papillary endobronchial squamous cell carcinoma incidentally discovered on routine imaging studies is described. The patient, a 75-year-old woman, underwent imaging studies as part of a standard evaluation for a fracture on the right side of the hip. Chest radiographs were unremarkable other than for a nodular opacity overlying the left hemidiaphragm. Computed tomography of the chest, however, demonstrated an elongated, irregular mass in the right lower lobe that appeared to be associated with an adjacent segmental right lower lobe bronchus. Endoscopy followed by surgical resection was undertaken, revealing a tan, soft mass measuring 1.5 x 1.3 x 0.8 cm that was confined to the bronchus and did not appear to extend into the surrounding lung parenchyma. Microscopically, the mass showed a papillary, superficial squamous cell carcinoma confined to the bronchial mucosa without invasion of adjacent structures. The pathological and imaging features of this unusual variant of bronchogenic carcinoma are reviewed as well as the radiological differential diagnosis of endobronchial lesions. To our knowledge, this is the first report that describes the computed tomographic features of this rare lesion.

Entities:  

Mesh:

Year:  2005        PMID: 16198957     DOI: 10.1016/j.anndiagpath.2005.05.007

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  2 in total

1.  Pulmonary papillary squamous cell carcinoma: a population-based analysis of incidence, treatment, and prognosis.

Authors:  Qingchen Yuan; Na Sun; Zibo Meng; Xiao Chen
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

2.  Incidence and therapeutic strategies for the management of pulmonary papillary cell carcinoma.

Authors:  Alvaro Martin; Kassem Harris
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.